Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 35

1.

Identifying and Supporting Nonpharmacological Dementia Interventions Ready for Pragmatic Trials: Results From an Expert Workshop.

Baier RR, Mitchell SL, Jutkowitz E, Mor V.

J Am Med Dir Assoc. 2018 Apr 13. pii: S1525-8610(18)30099-9. doi: 10.1016/j.jamda.2018.02.011. [Epub ahead of print] No abstract available.

PMID:
29656839
2.

"It's Like a Cyber-Security Blanket": The Utility of Remote Activity Monitoring in Family Dementia Care.

Mitchell LL, Peterson CM, Rud SR, Jutkowitz E, Sarkinen A, Trost S, Porta CM, Finlay JM, Gaugler JE.

J Appl Gerontol. 2018 Mar 1:733464818760238. doi: 10.1177/0733464818760238. [Epub ahead of print]

PMID:
29504488
3.

What we learned through asking about evidence: A model for interdisciplinary student engagement.

Finlay JM, Davila H, Whipple MO, McCreedy EM, Jutkowitz E, Jensen A, Kane RA.

Gerontol Geriatr Educ. 2018 Jan 24:1-15. doi: 10.1080/02701960.2018.1428578. [Epub ahead of print]

PMID:
29364792
4.

Pharmacologic Interventions to Prevent Cognitive Decline, Mild Cognitive Impairment, and Clinical Alzheimer-Type Dementia: A Systematic Review.

Fink HA, Jutkowitz E, McCarten JR, Hemmy LS, Butler M, Davila H, Ratner E, Calvert C, Barclay TR, Brasure M, Nelson VA, Kane RL.

Ann Intern Med. 2018 Jan 2;168(1):39-51. doi: 10.7326/M17-1529. Epub 2017 Dec 19.

PMID:
29255847
5.

Physical Activity Interventions in Preventing Cognitive Decline and Alzheimer-Type Dementia: A Systematic Review.

Brasure M, Desai P, Davila H, Nelson VA, Calvert C, Jutkowitz E, Butler M, Fink HA, Ratner E, Hemmy LS, McCarten JR, Barclay TR, Kane RL.

Ann Intern Med. 2018 Jan 2;168(1):30-38. doi: 10.7326/M17-1528. Epub 2017 Dec 19.

PMID:
29255839
6.

Societal and Family Lifetime Cost of Dementia: Implications for Policy.

Jutkowitz E, Kane RL, Gaugler JE, MacLehose RF, Dowd B, Kuntz KM.

J Am Geriatr Soc. 2017 Oct;65(10):2169-2175. doi: 10.1111/jgs.15043. Epub 2017 Aug 17.

PMID:
28815557
7.

Interventions to Prevent Age-Related Cognitive Decline, Mild Cognitive Impairment, and Clinical Alzheimer’s-Type Dementia [Internet].

Kane RL, Butler M, Fink HA, Brasure M, Davila H, Desai P, Jutkowitz E, McCreedy E, Nelson VA, McCarten JR, Calvert C, Ratner E, Hemmy LS, Barclay T.

Rockville (MD): Agency for Healthcare Research and Quality (US); 2017 Mar.

8.

Prioritizing Future Research on Allopurinol and Febuxostat for the Management of Gout: Value of Information Analysis.

Jutkowitz E, Alarid-Escudero F, Choi HK, Kuntz KM, Jalal H.

Pharmacoeconomics. 2017 Oct;35(10):1073-1085. doi: 10.1007/s40273-017-0526-0.

PMID:
28631197
9.

Effects of Cognition, Function, and Behavioral and Psychological Symptoms on Medicare Expenditures and Health Care Utilization for Persons With Dementia.

Jutkowitz E, Kane RL, Dowd B, Gaugler JE, MacLehose RF, Kuntz KM.

J Gerontol A Biol Sci Med Sci. 2017 Jun 1;72(6):818-824. doi: 10.1093/gerona/glx035.

PMID:
28369209
10.

Effects of cognition, function, and behavioral and psychological symptoms on out-of-pocket medical and nursing home expenditures and time spent caregiving for persons with dementia.

Jutkowitz E, Kuntz KM, Dowd B, Gaugler JE, MacLehose RF, Kane RL.

Alzheimers Dement. 2017 Jul;13(7):801-809. doi: 10.1016/j.jalz.2016.12.011. Epub 2017 Feb 1.

11.

The cost-effectiveness of HLA-B*5801 screening to guide initial urate-lowering therapy for gout in the United States.

Jutkowitz E, Dubreuil M, Lu N, Kuntz KM, Choi HK.

Semin Arthritis Rheum. 2017 Apr;46(5):594-600. doi: 10.1016/j.semarthrit.2016.10.009. Epub 2016 Nov 1.

12.

Effect of Workplace Weight Management on Health Care Expenditures and Quality of Life.

Michaud TL, Nyman JA, Jutkowitz E, Su D, Dowd B, Abraham JM.

J Occup Environ Med. 2016 Nov;58(11):1073-1078.

PMID:
27820756
13.

Consistency of dementia caregiver intervention classification: an evidence-based synthesis.

Gaugler JE, Jutkowitz E, Shippee TP, Brasure M.

Int Psychogeriatr. 2017 Jan;29(1):19-30. doi: 10.1017/S1041610216001514. Epub 2016 Sep 27. Review.

14.

Reducing neuropsychiatric symptoms in persons with dementia and associated burden in family caregivers using tailored activities: Design and methods of a randomized clinical trial.

Gitlin LN, Piersol CV, Hodgson N, Marx K, Roth DL, Johnston D, Samus Q, Pizzi L, Jutkowitz E, Lyketsos CG.

Contemp Clin Trials. 2016 Jul;49:92-102. doi: 10.1016/j.cct.2016.06.006. Epub 2016 Jun 21.

15.

Risk Factors Associated With Cognitive, Functional, and Behavioral Trajectories of Newly Diagnosed Dementia Patients.

Jutkowitz E, MacLehose RF, Gaugler JE, Dowd B, Kuntz KM, Kane RL.

J Gerontol A Biol Sci Med Sci. 2017 Feb;72(2):251-258. doi: 10.1093/gerona/glw079. Epub 2016 Apr 29.

16.

Nonpharmacologic Interventions for Agitation and Aggression in Dementia [Internet].

Brasure M, Jutkowitz E, Fuchs E, Nelson VA, Kane RA, Shippee T, Fink HA, Sylvanus T, Ouellette J, Butler M, Kane RL.

Rockville (MD): Agency for Healthcare Research and Quality (US); 2016 Mar.

17.

Care-Delivery Interventions to Manage Agitation and Aggression in Dementia Nursing Home and Assisted Living Residents: A Systematic Review and Meta-analysis.

Jutkowitz E, Brasure M, Fuchs E, Shippee T, Kane RA, Fink HA, Butler M, Sylvanus T, Kane RL.

J Am Geriatr Soc. 2016 Mar;64(3):477-88. doi: 10.1111/jgs.13936. Review.

PMID:
27000321
18.

For what illnesses is a disease management program most effective?

Jutkowitz E, Nyman JA, Michaud TL, Abraham JM, Dowd B.

J Occup Environ Med. 2015 Feb;57(2):117-23. doi: 10.1097/JOM.0000000000000385.

PMID:
25654512
19.

Cost-effectiveness of a community-integrated home-based depression intervention in older African Americans.

Pizzi LT, Jutkowitz E, Frick KD, Suh DC, Prioli KM, Gitlin LN.

J Am Geriatr Soc. 2014 Dec;62(12):2288-95. doi: 10.1111/jgs.13146.

20.

Cost-effectiveness of allopurinol and febuxostat for the management of gout.

Jutkowitz E, Choi HK, Pizzi LT, Kuntz KM.

Ann Intern Med. 2014 Nov 4;161(9):617-26. doi: 10.7326/M14-0227.

PMID:
25364883

Supplemental Content

Loading ...
Support Center